1. Home
  2. ITOS vs LWAY Comparison

ITOS vs LWAY Comparison

Compare ITOS & LWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITOS
  • LWAY
  • Stock Information
  • Founded
  • ITOS 2011
  • LWAY 1986
  • Country
  • ITOS United States
  • LWAY United States
  • Employees
  • ITOS N/A
  • LWAY N/A
  • Industry
  • ITOS Biotechnology: Biological Products (No Diagnostic Substances)
  • LWAY Packaged Foods
  • Sector
  • ITOS Health Care
  • LWAY Consumer Staples
  • Exchange
  • ITOS Nasdaq
  • LWAY Nasdaq
  • Market Cap
  • ITOS 381.2M
  • LWAY 376.4M
  • IPO Year
  • ITOS 2020
  • LWAY 1987
  • Fundamental
  • Price
  • ITOS $10.17
  • LWAY $26.47
  • Analyst Decision
  • ITOS Hold
  • LWAY Hold
  • Analyst Count
  • ITOS 6
  • LWAY 1
  • Target Price
  • ITOS $10.60
  • LWAY N/A
  • AVG Volume (30 Days)
  • ITOS 1.5M
  • LWAY 46.7K
  • Earning Date
  • ITOS 08-07-2025
  • LWAY 08-12-2025
  • Dividend Yield
  • ITOS N/A
  • LWAY N/A
  • EPS Growth
  • ITOS N/A
  • LWAY N/A
  • EPS
  • ITOS N/A
  • LWAY 0.67
  • Revenue
  • ITOS $35,000,000.00
  • LWAY $188,277,000.00
  • Revenue This Year
  • ITOS N/A
  • LWAY $12.53
  • Revenue Next Year
  • ITOS N/A
  • LWAY $12.08
  • P/E Ratio
  • ITOS N/A
  • LWAY $39.41
  • Revenue Growth
  • ITOS 177.89
  • LWAY 12.84
  • 52 Week Low
  • ITOS $4.80
  • LWAY $10.06
  • 52 Week High
  • ITOS $18.13
  • LWAY $27.29
  • Technical
  • Relative Strength Index (RSI)
  • ITOS 58.43
  • LWAY 65.90
  • Support Level
  • ITOS $10.10
  • LWAY $24.40
  • Resistance Level
  • ITOS $10.47
  • LWAY $27.00
  • Average True Range (ATR)
  • ITOS 0.12
  • LWAY 0.80
  • MACD
  • ITOS -0.06
  • LWAY 0.11
  • Stochastic Oscillator
  • ITOS 23.08
  • LWAY 80.37

About ITOS iTeos Therapeutics Inc.

ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.

About LWAY Lifeway Foods Inc.

Lifeway Foods Inc is engaged in manufacturing probiotic, cultured, functional dairy health food products. Its primary product is drinkable kefir which is a cultured dairy product. Its product categories are Drinkable Kefir which is the key revenue-driving product, European-style soft cheeses, Cream, ProBugs, Frozen Kefir and Other dairy. The company manufacture and market products under the Lifeway and Fresh Made brand names, as well as under private labels on behalf of customers. It sells the products through direct sales force, brokers, and distributors.

Share on Social Networks: